A recent article published in BiopharmaDive debunks some of the myths around electronic Clinical Outcome Assessment (eCOA). One of the most common misunderstandings about using eCOA is that it is suitable for large institutions only, although smaller companies widely use it in clinical trials.
Many believe that paper COA data is reliable, when in fact it often misses core information and can be hard to read due to poor handwriting, which makes it challenging to analyze the data and evaluate the patient’s progress. Moreover, growing evidence shows that patients prefer electronic forms over paper-based methods as they are much faster to complete. Read the full article to learn more about the advantages eCOA offers for your practice
The DADOS platform allows to electronically collect and manage data related to treatment outcomes in real-time.